SCHEMBL14918455

SCHEMBL14918455

CC(C)(CCCCc1noc(C(F)(F)F)n1)C(=O)Nc1cccnc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 2/20 0.51
HDAC4 P56524 2/20 0.51
HDAC1 Q13547 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
NPC1 O15118 6/20 0.42
RAB9A P51151 6/20 0.42
KLF5 Q13887 1/20 0.42
HSD17B10 Q99714 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
ALDH1A1 P00352 2/20 0.40
PKM P14618 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
CYP1A2 P05177 2/20 0.40
CYP3A4 P08684 2/20 0.40
CYP2C9 P11712 2/20 0.40
CYP2C19 P33261 2/20 0.40
CYP2D6 P10635 1/20 0.40
LMNA P02545 2/20 0.39
USP2 O75604 1/20 0.39
NAMPT P43490 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14918730 0.88 HDAC6 (0.40) HDAC6HDAC4HDAC1HDAC8LMNA
SCHEMBL14918928 0.84 HDAC4 (0.45) HDAC6HDAC4HDAC1HDAC8NPC1
SCHEMBL14918432 0.84 HDAC8 (0.45) HDAC6HDAC4HDAC1HDAC8NPC1
SCHEMBL14918896 0.84 MEN1 (0.41) HDAC6HDAC4HDAC1HDAC8NPC1
SCHEMBL14918429 0.84 HDAC4 (0.54) HDAC6HDAC4HDAC1HDAC8NPC1
SCHEMBL14917800 0.83 HDAC6 (0.41) HDAC6HDAC4HDAC1HDAC8NPC1
SCHEMBL14918877 0.83 HDAC4 (0.56) HDAC6HDAC4HDAC1HDAC8NPC1
SCHEMBL14918567 0.83 HDAC4 (0.56) HDAC6HDAC4HDAC1HDAC8NPC1
SCHEMBL14919138 0.83 HDAC4 (0.56) HDAC6HDAC4HDAC1HDAC8NPC1
SCHEMBL14918538 0.83 LMNA (0.56) HDAC6HDAC4HDAC1HDAC8NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013066836-A1 COMPOUNDS AND METHODS GLAXOSMITHKLINE LLC (US) 2013-05-10 WO claimed
WO-2013066836-A1 COMPOUNDS AND METHODS GLAXOSMITHKLINE LLC (US) 2013-05-10 WO disclosed